{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:52:36Z","timestamp":1776995556917,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T00:00:00Z","timestamp":1461801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.nefro.2016.01.014","type":"journal-article","created":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T06:56:16Z","timestamp":1465023376000},"page":"489-495","source":"Crossref","is-referenced-by-count":8,"title":["Autoanticuerpos frente a prote\u00ednas de la v\u00eda alternativa del complemento en enfermedad renal"],"prefix":"10.1016","volume":"36","author":[{"given":"Pilar","family":"Nozal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"L\u00f3pez-Trascasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2016.01.014_bib0180","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: A key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ackd.2012.02.015","article-title":"Complement in glomerular disease","volume":"19","author":"Vernon","year":"2012","journal-title":"Adv Chronic Kidney Dis."},{"key":"10.1016\/j.nefro.2016.01.014_bib0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molimm.2013.05.009","article-title":"Autoantibodies against complement components and functional consequences","volume":"56","author":"Dragon-Durey","year":"2013","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.116.1.1","article-title":"C3 nephritic factor (C3NeF): Stabilization of fluid phase and cell-bound alternative pathway convertase","volume":"116","author":"Daha","year":"1976","journal-title":"J Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0200","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ki.2012.250","article-title":"Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation","volume":"82","author":"Paixao-Cavalcante","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2016.01.014_bib0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0090-1229(90)90144-F","article-title":"Two types of C3 nephritic factor: Properdin-dependent C3NeF and properdin-independent C3NeF","volume":"56","author":"Tanuma","year":"1990","journal-title":"Clin Immunol Immunopathol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0210","first-page":"33","article-title":"Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor","volume":"43","author":"Daha","year":"1981","journal-title":"Immunology."},{"key":"10.1016\/j.nefro.2016.01.014_bib0215","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2016.01.014_bib0220","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","article-title":"Membranoproliferative glomerulonephritis type II (dense deposit disease): An update","volume":"16","author":"Appel","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: Report of 35 cases and review of the literature","volume":"83","author":"Misra","year":"2004","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.nefro.2016.01.014_bib0230","first-page":"609","article-title":"C3 nephritic factor and SLE: Report of 4 cases and review of the literature","volume":"87","author":"Walport","year":"1994","journal-title":"QJM."},{"key":"10.1016\/j.nefro.2016.01.014_bib0235","first-page":"1747","article-title":"Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity","volume":"9","author":"Fremeaux-Bacchi","year":"1994","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2016.01.014_bib0240","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S0022-3476(05)82711-8","article-title":"Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event","volume":"116","author":"Spitzer","year":"1990","journal-title":"J Pediatr."},{"key":"10.1016\/j.nefro.2016.01.014_bib0245","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.molimm.2010.02.002","article-title":"B autoantibody in dense deposit disease","volume":"47","author":"Strobel","year":"2010","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0250","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1056\/NEJMc1107484","article-title":"Combined C3b and factor B autoantibodies and MPGN type II","volume":"365","author":"Chen","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefro.2016.01.014_bib0255","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0260","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0030-1262885","article-title":"Anti-factor H autoantibody-associated hemolytic uremic syndrome: Review of literature of the autoimmune form of HUS","volume":"36","author":"Dragon-Durey","year":"2010","journal-title":"Semin Thromb Hemost."},{"key":"10.1016\/j.nefro.2016.01.014_bib0265","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ki.2013.373","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefro.2016.01.014_bib0270","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J Med Genet."},{"key":"10.1016\/j.nefro.2016.01.014_bib0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2215\/CJN.01260212","article-title":"Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome","volume":"8","author":"Hofer","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0280","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2016.01.014_bib0285","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.nefro.2016.01.014_bib0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ndt\/gfp388","article-title":"Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome","volume":"25","author":"Strobel","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefro.2016.01.014_bib0295","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0034-1375296","article-title":"Genetics of atypical hemolytic uremic syndrome (aHUS)","volume":"40","author":"Rodriguez de Cordoba","year":"2014","journal-title":"Semin Thromb Hemost."},{"key":"10.1016\/j.nefro.2016.01.014_bib0300","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1200679","article-title":"Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome","volume":"189","author":"Blanc","year":"2012","journal-title":"J Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0305","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M114.630871","article-title":"The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H related protein 1 supporting a novel model for induction of autoimmunity in this disease","author":"Bhattacharjee","year":"2015","journal-title":"J Biol Chem."},{"key":"10.1016\/j.nefro.2016.01.014_bib0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molimm.2015.12.005","article-title":"Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome","volume":"70","author":"Nozal","year":"2016","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0375","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J Exp Med."},{"key":"10.1016\/j.nefro.2016.01.014_bib0335","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: A unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0340","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.07110810","article-title":"Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement","volume":"6","author":"Sethi","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0345","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ckj\/sfs002","article-title":"Anti-factor H antibody affecting factor H cofactor activity in a patient with dense deposit disease","volume":"5","author":"Nozal","year":"2012","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.nefro.2016.01.014_bib0330","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1093\/ndt\/gfr436","article-title":"Three kidneys, 2 diseases, one antibody?","volume":"26","author":"Lorcy","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2016.01.014_bib0350","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","article-title":"Factor H autoantibodies in membranoproliferative glomerulonephritis","volume":"52","author":"Goodship","year":"2012","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0355","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.1402770","article-title":"Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: One target, 2 diseases","volume":"194","author":"Blanc","year":"2015","journal-title":"J Immunol."},{"key":"10.1016\/j.nefro.2016.01.014_bib0360","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2215\/CJN.05750611","article-title":"Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: Disease-associated or an epiphenomenon?","volume":"7","author":"Kavanagh","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2016.01.014_bib0365","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-015-0032-6","article-title":"Case report: Lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation","volume":"16","author":"Nozal","year":"2015","journal-title":"BMC Nephrol."}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699516300315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699516300315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T19:16:30Z","timestamp":1692386190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699516300315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0211699516300315"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2016.01.014","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}